fingolimod hydrochloride has been researched along with Adhalinopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heydemann, A | 1 |
1 other study(ies) available for fingolimod hydrochloride and Adhalinopathies
| Article | Year |
|---|---|
Severe murine limb-girdle muscular dystrophy type 2C pathology is diminished by FTY720 treatment.
Topics: Animals; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Mice, Inbred DBA; Mice, Transgenic; Random Allocation; Sarcoglycanopathies; Severity of Illness Index; Treatment Outcome | 2017 |